
Skip this Video
Table 1 An overview of key clinical trials of afatinib in lung cancer Yu, H. A. & Pao, W. (2013) Afatinib—new therapy option for EGFR-mutant lung cancer Nat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2013.154